These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy. Dourmishev LA Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112 [TBL] [Abstract][Full Text] [Related]
3. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701 [TBL] [Abstract][Full Text] [Related]
4. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. Sunderkötter C; Nast A; Worm M; Dengler R; Dörner T; Ganter H; Hohlfeld R; Melms A; Melzer N; Rösler K; Schmidt J; Sinnreich M; Walter MC; Wanschitz J; Wiendl H J Dtsch Dermatol Ges; 2016 Mar; 14(3):321-38. PubMed ID: 26972210 [TBL] [Abstract][Full Text] [Related]
5. [Dermatomyositis and juvenile dermatomyositis]. Dressler F; Maurer B Z Rheumatol; 2023 Apr; 82(3):233-245. PubMed ID: 35486206 [TBL] [Abstract][Full Text] [Related]
10. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report. Jevtic D; Dharmah U; Bahar M J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369 [TBL] [Abstract][Full Text] [Related]
11. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis]. Genth E Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Mainetti C; Terziroli Beretta-Piccoli B; Selmi C Clin Rev Allergy Immunol; 2017 Dec; 53(3):337-356. PubMed ID: 29090371 [TBL] [Abstract][Full Text] [Related]
13. [Classic/amyopathic dermatomyositis]. Vilas AP; Fiúza T Acta Med Port; 2000; 13(5-6):287-94. PubMed ID: 11234494 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroids in Myositis and Scleroderma. Postolova A; Chen JK; Chung L Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554 [TBL] [Abstract][Full Text] [Related]
15. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. Wu JQ; Lu MP; Reed AM World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011 [TBL] [Abstract][Full Text] [Related]
16. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis. Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412 [TBL] [Abstract][Full Text] [Related]
17. Management of cutaneous dermatomyositis: current therapeutic options. Quain RD; Werth VP Am J Clin Dermatol; 2006; 7(6):341-51. PubMed ID: 17173468 [TBL] [Abstract][Full Text] [Related]
19. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis]. Váncsa A; Dankó K Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067 [TBL] [Abstract][Full Text] [Related]